Brussels, 18/12/2014 (Agence Europe) - If a human ovum which is parthenogenically activated is not capable of developing into a human being, in other words it can under no circumstances lead to a human being, it can be patented, the Court of Justice of the EU ruled, in a verdict (case C-364/13) returned on Thursday 18 December, which unblocks the biotechnological development of so-called “regenerative” medicine.
The Court was ruling in a dispute in the United Kingdom, where the...